2
Announcements
Trials
Browse
Landscape
Status
Enrolling by invitation
1
Sponsor Class
NETWORK
1
Study Type
Observational
1
Sponsor
Conditions
Neoplasms
8
Breast Neoplasms
6
Malnutrition
5
Stomach Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Pancreatic Neoplasms
3
Lung Neoplasms
3
Colonic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Prostatic Neoplasms
2
Lymphoma
2
Locally Advanced Head and Neck Carcinoma
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Cachexia
2
Biliary Tract Neoplasms
2
Wilms Tumor
1
Surgery--Complications
1
Sarcoma
1
Prostatic Intraepithelial Neoplasia
1
Peripheral Nervous System Diseases
1
Peptic Ulcer
1
Osteoporosis
1
Nutrition Related Cancer
1
Neurotoxicity Syndromes
1
Neurofibromatosis 1
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neoplasm Metastasis
1
Interventions
Irinotecan
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Oxaliplatin
4
Fluorouracil
4
Capecitabine
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Leucovorin
3
pembrolizumab
2
Sorafenib
2
Paclitaxel
2
Nivolumab
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Bupivacaine
2
Aspirin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
penpulimab
1
ozanimod
1
lutetium Lu 177 dotatate
1
linifanib
1
hetrombopag
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Dietary Supplements
×
Clear all
NCT07035132
2025-10-07
NORMA
Outcomes'10
Enrolling by invitation
132 enrolled